<DOC>
	<DOCNO>NCT03001180</DOCNO>
	<brief_summary>The study use participant tissue previously collect stored tissue bank maintain Department Hematology/Oncology well tissue bank future participant undergo prescribed surgical resection vascular anomaly interest propose study . The principle investigator study staff also obtain blood participant .</brief_summary>
	<brief_title>Identification Biomarkers Patients With Vascular Anomalies</brief_title>
	<detailed_description>While vascular anomaly rare disease , life-threatening devastating affect child family . Advances diagnosis , monitor therapy significantly improve non-invasive biomarkers sensitive specific identify . Identification VEGF-D biomarker LAM ( Lymphangiomyomatosis ) patient excellent example blood biomarker impact diagnosis treatment . Biomarkers may also give insight disease pathogenesis , often release cell contribute disease process . The study protocol characterize define biomarkers aid diagnosis treatment patient vascular anomaly . The differential diagnosis entity challenge , especially GLA versus KLA KLA versus KHE . Obtaining tissue biopsy help diagnosis actually worsen disease identification specific blood biomarkers highly desirable . Studies measure angiogenic factor serum plasma sample baseline therapy .</detailed_description>
	<mesh_term>Congenital Abnormalities</mesh_term>
	<mesh_term>Vascular Malformations</mesh_term>
	<mesh_term>Hemangioendothelioma</mesh_term>
	<mesh_term>Sarcoma , Kaposi</mesh_term>
	<mesh_term>Kasabach-Merritt Syndrome</mesh_term>
	<mesh_term>Osteolysis , Essential</mesh_term>
	<criteria>Any patient lab draw standard care blood drawn study consented/ assent . All patient undergo surgical procedure sclerotherapy currently consent participation tissue bank .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Generalized Lymphatic Anomaly</keyword>
	<keyword>Vascular Anomaly</keyword>
	<keyword>Kaposiform Hemangioendothelioma</keyword>
	<keyword>Kaposiform Lymphangiomatosis</keyword>
	<keyword>Vascular Endothelial Growth Factor</keyword>
	<keyword>Biomarkers</keyword>
	<keyword>GLA</keyword>
	<keyword>KLA</keyword>
	<keyword>KHE</keyword>
	<keyword>GSD</keyword>
</DOC>